fbpx

Brain Cancer

Cerebral Glioblastoma

Female, 42 years

Patient Internal 103598333

ICD-10 code

C71.8 Malignant Neoplasm of Overlapping Sites of Brain

Diagnosis (Incl. Metastases/Stage) and Year

February 2021
Glioblastoma (WHO grade IV), IDH(-), TERT(-), MGMT(+), Chromosome 7 Trisomy and Chromosome 10 Monosomy, BRAF(-).

Previous Treatment

Radiation Therapy, Chemotherapy (Temozolomide + Lomustine).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of ~ 14 months from diagnosis.

Treatment Provided

Autologous DCV (5 doses) and CIK (4doses) over a period of 3 months.

Patient Survival/Condition and Year
Date of Review: 15/10/2023

The patient has survived 18 months from the diagnosis. It can be concluded that Immunotherapy, alongside Radiation Therapy and Chemotherapy, has extended the patient’s survival by 4 months over the median survival.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.